Bentham Science Logo

Letters in Drug Design & Discovery

Volume 16, 12 Issues, 2019
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

Ranking and Category

  • 57th of 61 in

    Chemistry, Medicinal

Order Your Article Before Print

Endorsements

"Letters in Drug Design & Discovery should be available in every library in the pharmaceutical industry and in universities."

R. F. Borne, Associate Director
Laboratory for Applied Drug Design and Synthesis, The University of Mississippi, USA
"Letters in Drug Design & Discovery represents an important review journal of great value to pharmaceutical scientists."

Errol B. De Souza
President & CEO, Archemix Corporation, USA
"Letters in Drug Design & Discovery will fill an important niche for the translation of exciting new research in the fields of medicinal chemistry and drug development."

Kenneth Maiese, Professor Director
Division of Cellular and Molecular Cerebral Ischemia, Wayne State University School of Medicine, USA
"Letters in Drug Design & Discovery is an important new journal to experts and anyone interested in the pharmaceutical sciences from both industry as well as academia."

Tomi K. Sawyer
Vice-President, Drug Discovery, ARIAD Pharmaceuticals, USA
"Letters in Drug Design & Discovery represents an important new journal of great value to pharmaceutical scientists."

Henry F. VanBrocklin
Lawrence Berkeley Laboratory, USA

Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
Czech Republic

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog